Latest serological survey conducted in Delhi revealed one in three or 33% of the population has developed antibodies against coronavirus. The initial analysis of third sero survey included surveillance of 17,000 samples which had been collected from 11 districts. The official outcome of survey is to be announced next week. As per the survey out ...

Results of the first serological surveillance study conducted in city of Pune reveal that 51.5% of surveyed population has developed antibodies against the novel coronavirus. The study was conducted in five wards of city within Pune civic body limits, with high incidence of cases. The study shows that in these five highly infected wards that ...

A portion of people who had applied to enroll for AIIMS coronavirus vaccine trial for India’s first indigenous vaccine, Covaxin have already developed antibodies against the novel coronavirus. The sources at AIIMS said that about 20% of the enrolled people in trial have thus been rendered unfit for the trial. It has been two weeks ...